Tempo Therapeutics raises $14.5 million for regenerative tissue technology
Pulse2.com reports the oversubscribed round is intended to advance Tempo's technology toward potential regulatory clearance and commercialization.
TLDR
Tempo Therapeutics has closed an oversubscribed $14.5 million financing round, Pulse2.com reports. The funding is intended to advance its Microporous Annealed Particle regenerative technology through potential regulatory clearance and commercialization.
Combined views
32
1 Source, first seen ago